Waters Co. (NYSE:WAT) Shares Bought by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH lifted its position in Waters Co. (NYSE:WAT) by 2,134.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,921 shares of the medical instruments supplier’s stock after acquiring an additional 5,656 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in Waters were worth $2,038,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. IMPACTfolio LLC grew its position in shares of Waters by 4.2% in the 4th quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier’s stock worth $264,000 after acquiring an additional 32 shares in the last quarter. Mountain Pacific Investment Advisers Inc. ID lifted its holdings in shares of Waters by 0.3% in the 4th quarter. Mountain Pacific Investment Advisers Inc. ID now owns 11,469 shares of the medical instruments supplier’s stock worth $3,776,000 after purchasing an additional 34 shares during the last quarter. Hohimer Wealth Management LLC lifted its holdings in shares of Waters by 2.7% in the 4th quarter. Hohimer Wealth Management LLC now owns 1,354 shares of the medical instruments supplier’s stock worth $446,000 after purchasing an additional 35 shares during the last quarter. Armstrong Henry H Associates Inc. lifted its holdings in shares of Waters by 0.4% in the 1st quarter. Armstrong Henry H Associates Inc. now owns 10,819 shares of the medical instruments supplier’s stock worth $3,724,000 after purchasing an additional 40 shares during the last quarter. Finally, Czech National Bank lifted its holdings in shares of Waters by 0.5% in the 1st quarter. Czech National Bank now owns 10,403 shares of the medical instruments supplier’s stock worth $3,581,000 after purchasing an additional 48 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Insider Buying and Selling

In related news, Director Richard H. Fearon bought 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 28th. The shares were acquired at an average cost of $332.90 per share, for a total transaction of $332,900.00. Following the acquisition, the director now directly owns 1,653 shares of the company’s stock, valued at approximately $550,283.70. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Waters news, Director Richard H. Fearon purchased 1,000 shares of the stock in a transaction dated Tuesday, May 28th. The shares were acquired at an average price of $332.90 per share, for a total transaction of $332,900.00. Following the completion of the acquisition, the director now owns 1,653 shares of the company’s stock, valued at approximately $550,283.70. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Christopher A. Kuebler sold 4,000 shares of Waters stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $361.64, for a total value of $1,446,560.00. Following the transaction, the director now owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. Insiders own 0.82% of the company’s stock.

Waters Stock Up 0.6 %

WAT opened at $284.49 on Wednesday. Waters Co. has a one year low of $231.90 and a one year high of $367.21. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.30 and a current ratio of 1.94. The stock’s fifty day moving average is $315.69 and its 200-day moving average is $323.60. The company has a market capitalization of $16.88 billion, a PE ratio of 27.92, a P/E/G ratio of 4.62 and a beta of 0.95.

Waters (NYSE:WAT) last issued its earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.10 by $0.11. The business had revenue of $636.80 million for the quarter, compared to analysts’ expectations of $635.57 million. Waters had a return on equity of 66.59% and a net margin of 20.75%. The company’s quarterly revenue was down 7.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.49 EPS. On average, equities analysts predict that Waters Co. will post 11.85 EPS for the current fiscal year.

Analyst Ratings Changes

WAT has been the topic of several recent research reports. Evercore ISI cut their price target on Waters from $320.00 to $300.00 and set an “in-line” rating on the stock in a report on Tuesday. Stifel Nicolaus raised their price target on Waters from $330.00 to $332.00 and gave the stock a “hold” rating in a report on Wednesday, May 8th. TD Cowen lifted their target price on Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research note on Wednesday, May 8th. Barclays cut their target price on Waters from $295.00 to $275.00 and set an “underweight” rating on the stock in a research note on Friday, June 28th. Finally, Jefferies Financial Group began coverage on Waters in a research note on Monday, June 3rd. They set a “hold” rating and a $320.00 target price on the stock. One equities research analyst has rated the stock with a sell rating and eleven have given a hold rating to the company. According to MarketBeat.com, Waters has an average rating of “Hold” and an average target price of $301.20.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.